Veuillez noter que la page demandée n’est pas disponible dans la langue par défaut sélectionnée. Vous utilisez notre plateforme dans une autre langue maintenant.
This statistic shows the turnover of non-reimbursable medicines in metropolitan France from 2010 to 2016, in manufacturing price excluding tax and in million euros. In 2016, the market for non-refundable medicines sold in France represented around two billion euros.
Turnover of non-reimbursable medicines in France from 2010 to 2016, in manufacturer price excluding taxes* (in million euros)
Loading statistic...
Basic Account
Get to know the platform
You only have access to basic statistics.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Basic Statistic Global pharmaceutical revenue by technology 2012-2026
- Basic Statistic Total turnover of the French medicines market 2010-2018
- Basic Statistic Distribution of the turnover of the pharmaceuticals market in France 2017, by segment
- Basic Statistic Definition of specialty drugs by PBMs and pharmacy executives 2011
- Basic Statistic Trade balance in high technology sectors of EU countries 2022
- Premium Statistic Pharmaceutical exports value in Jamaica 2014-2021
- Premium Statistic Pharmaceutical exports value in Nicaragua 2014-2022
- Premium Statistic Pharmaceutical exports value in Panama 2013-2021
- Premium Statistic Pharmaceutical exports value in Paraguay 2014-2022
- Premium Statistic Pharmaceutical exports value in El Salvador 2014-2022
About the region
10
- Basic Statistic Companies in the manufacture of pharmaceutical products in France 2011-2022
- Basic Statistic Number of employees of pharmaceutical companies by region France 2020
- Basic Statistic Turnover of medicines sold in retail pharmacies in France 2005-2018
- Basic Statistic Turnover of medicines distributed in hospitals in France 2010-2018
- Basic Statistic Breakdown of the workforce of Sanofi 2018, by geographical location
- Basic Statistic Sanofi's workforce in 2018, by segment
- Basic Statistic Breakdown of employees of drug companies by age France 2014
- Premium Statistic Boiron laboratories turnover in 2022, by region
- Premium Statistic Net profit of Boiron laboratories 2013-2022, per share
- Premium Statistic Net investments of Boiron laboratories 2014-2022
Selected statistics
7
- Premium Statistic Pfizer's ad spending 2006-2023
- Premium Statistic Annual revenue of Sinopharm 2010-2022
- Premium Statistic Number of employees at Sinopharm 2011-2022
- Premium Statistic Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Premium Statistic Revenue of Sinopharm 2011-2022, by category
- Basic Statistic M&A capacities - changes for the global pharma industry 2008-2015
- Premium Statistic Enterprise and brand value of Shoppers Drug Mart in 2012
Other regions
10
- Premium Statistic Pharmaceutical industry: global breakdown in the sale of new drugs 2004-2022
- Basic Statistic Share of biotech firms active in COVID-19 R&D in Italy 2020
- Basic Statistic Leading antianginal drugs dispensed in England 2022, by item number
- Premium Statistic Size of the U.S. vaccine market by age 2014-2024
- Premium Statistic Brazil: Hypera Pharma's ad spending 2016-2018
- Premium Statistic Revenue market share of opioid analgesics sold in Spain by company 2017-2018
- Premium Statistic Parapharmaceuticals sales in Russia 2019-2020, by product
- Premium Statistic Revenue generated by high-tech companies through new products 2021, by industry
- Premium Statistic Share of expenditure on pharmaceuticals in Denmark by type 2022
- Premium Statistic Number of pharmacies in Norway 2009-2024
Related statistics
9
- Premium Statistic Turnover of Boiron laboratories in North America 2022, by country
- Premium Statistic Turnover of the nonproprietary drugs segment of Boiron in 2022, by region
- Premium Statistic Share capital of Boiron laboratories 2012-2022
- Premium Statistic Global turnover of Boiron laboratories 2012-2022
- Premium Statistic Turnover of Boiron laboratories abroad 2012-2022
- Premium Statistic Boiron's stock price at the end of the year 2012-2022
- Premium Statistic EBITDA of Boiron laboratories 2012-2022
- Premium Statistic Cashflow of Boiron laboratories 2013-2022
- Premium Statistic Boiron laboratories' market capitalization at the end of the year 2012-2022
Further related statistics
10
- Merck & Co - expenditure on research and development 2006-2023
- Merck & Co total assets 2009-2023
- Sanofi's total assets 2007-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- AstraZeneca's expenditure on research and development 2006-2023
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Johnson & Johnson's number of employees 2004-2023
- Sales of Johnson & Johnson 2006-2023 by region
- CVS Health's total assets 2005-2023
Further Content: You might find this interesting as well
Statistics
- Merck & Co - expenditure on research and development 2006-2023
- Merck & Co total assets 2009-2023
- Sanofi's total assets 2007-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- AstraZeneca's expenditure on research and development 2006-2023
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Johnson & Johnson's number of employees 2004-2023
- Sales of Johnson & Johnson 2006-2023 by region
- CVS Health's total assets 2005-2023
LEEM. (September 1, 2017). Turnover of non-reimbursable medicines in France from 2010 to 2016, in manufacturer price excluding taxes* (in million euros) [Graph]. In Statista. Retrieved May 29, 2024, from https://www.statista.com/statistics/783748/non-reimbursable-drug-sales-france/
LEEM. "Turnover of non-reimbursable medicines in France from 2010 to 2016, in manufacturer price excluding taxes* (in million euros)." Chart. September 1, 2017. Statista. Accessed May 29, 2024. https://www.statista.com/statistics/783748/non-reimbursable-drug-sales-france/
LEEM. (2017). Turnover of non-reimbursable medicines in France from 2010 to 2016, in manufacturer price excluding taxes* (in million euros). Statista. Statista Inc.. Accessed: May 29, 2024. https://www.statista.com/statistics/783748/non-reimbursable-drug-sales-france/
LEEM. "Turnover of Non-reimbursable Medicines in France from 2010 to 2016, in Manufacturer Price excluding Taxes* (in Million Euros)." Statista, Statista Inc., 1 Sep 2017, https://www.statista.com/statistics/783748/non-reimbursable-drug-sales-france/
LEEM, Turnover of non-reimbursable medicines in France from 2010 to 2016, in manufacturer price excluding taxes* (in million euros) Statista, https://www.statista.com/statistics/783748/non-reimbursable-drug-sales-france/ (last visited May 29, 2024)
Turnover of non-reimbursable medicines in France from 2010 to 2016, in manufacturer price excluding taxes* (in million euros) [Graph], LEEM, September 1, 2017. [Online]. Available: https://www.statista.com/statistics/783748/non-reimbursable-drug-sales-france/